The advent of cannabis as a viable U.S. industry has created the need for supportable and objective valuations, especially for merger and acquisition work. But rendering a supportable valuation opinion for cannabis companies is particularly challenging

Speakers: Claudia Z. Springer Aron Izower

Event Type: CLE / CPD, Webinar

Start Date/Time:
7 November 2019, 12:00 PM ET
End Date/Time:
7 November 2019, 1:00 PM ET

Complicating factors include:

  • The regulatory and legal framework for cannabis companies and the impact to financial projections
  • Complex tax, banking and securities issues
  • Lack of empirical data for valuations in this emerging industry
  • Intellectual property enforcement issues that uniquely impact valuations in the cannabis industry 

Join us for an overview of the complicated issues facing cannabis company transactions.